HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Playtex

This article was originally published in The Rose Sheet

Executive Summary

Playtex: Sales of sun and skin care products, primarily the Banana Boat line, grew by 28% in the first fiscal quarter of 1995 (ended April 1), fueling the company's 7.9% first quarter sales gain to $132.8 mil. Playtex' first quarter performance also benefited from a 23% sales gain by the company's infant care products. Sales of the company's tampon lines, including Playtex and Ultimates tampons, slipped 6% due to "an unusually strong quarter in the prior year and a higher level of competitive activity" in the quarter, Playtex reported. Net earnings declined 32% to $3.8 mil., reflecting the combination of lower operating earnings and higher interest costs versus the first quarter of 1994, the company explained...

Playtex: Sales of sun and skin care products, primarily the Banana Boat line, grew by 28% in the first fiscal quarter of 1995 (ended April 1), fueling the company's 7.9% first quarter sales gain to $132.8 mil. Playtex' first quarter performance also benefited from a 23% sales gain by the company's infant care products. Sales of the company's tampon lines, including Playtex and Ultimates tampons, slipped 6% due to "an unusually strong quarter in the prior year and a higher level of competitive activity" in the quarter, Playtex reported. Net earnings declined 32% to $3.8 mil., reflecting the combination of lower operating earnings and higher interest costs versus the first quarter of 1994, the company explained....

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel